Pharma & Biotech
You will receive alerts when there are new announcements on Aeolus Pharmaceuticals, Inc.
Only registered members can use this feature.
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. Its compound, AEOL 10150, is entering human clinical trials in oncology. AEOL 10150 had been tested in two Phase-I clinical trials.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.